CHAO Xiaoyun. Progress of methods for early prediction and screening of neonatal hyperbilirubinemia[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 129-132. DOI: 10.7619/jcmp.202015037
Citation: CHAO Xiaoyun. Progress of methods for early prediction and screening of neonatal hyperbilirubinemia[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 129-132. DOI: 10.7619/jcmp.202015037

Progress of methods for early prediction and screening of neonatal hyperbilirubinemia

More Information
  • Received Date: May 17, 2020
  • Published Date: September 09, 2020
  • Neonatal jaundice is the most common neonatal disease, the prognosis of most children are good, but a few newborns can develop into hyperbilirubinemia, and severe cases can also have acute bilirubin encephalopathy and nuclear jaundice, which can threaten the life safety of newborns. The key procedure to reduce the incidence of acute bilirubin encephalopathy is to prevent the occurrence of severe hyperbilirubinemia. Therefore, early prediction and screening of neonatal hyperbilirubinemia and risk factors assessment are the focus of research in the department of neonatology. At present, there is still a lack of single factor with high sensitivity in predicting neonatal hyperbilirubinemia, and it still needs to be combined with other risk factors for analysis. This study reviewed the risk factors, early predictors and early screening methods of neonatal hyperbilirubinemia in order to improve the prevention and treatment effect of neonatal hyperbilirubinemia.
  • MAISELS M J, MCDONAGH A F. Phototherapy for neonatal jaundice[J]. N Engl J Med, 2008, 358(9):920-928.
    LUCA D, CARNIELLI V P, PAOLILLO P. Neonatal hyperbilirubinemia and early discharge from the maternity ward[J]. Eur J Pediatr, 2009, 168(9):1025-1030.
    苗艳秋. 经皮胆红素动态监测对新生儿黄疸干预治疗作用的效果观察[J] 中国医药指南, 2016, 14(19):69-71.
    邵肖梅, 叶鸿瑁, 丘小汕, 等. 实用新生儿学[M]. 5版. 北京:人民卫生出版社, 2019:448-449.
    GÖKSEVER ÇELIK H, ÇELIK E, YILDIRIM G, et al. Do triple test results predict risk for neonatal hyperbilirubinemia[J]. Pak J Med Sci, 2017, 33(4):979-983.
    CHOU H C, CHIEN C T, TSAO P N, et al. Prediction of severe neonatal hyperbilirubinemia using cord blood hydrogen peroxide:a prospective study[J]. PLoS One, 2014, 9(1):e86797.
    HULZEBOS C V, VAN IMHOFF D E, BOS A F, et al. Usefulness of the bilirubin/albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants[J]. Arch Dis Child Fetal Neonatal Ed, 2008, 93(5):F384-F388.
    曾超军, 林少莲, 林昶. 新生儿高胆红素血症对婴幼儿期听力及学龄前发育的影响[J]. 中华耳科学杂志, 2020, 18(1):68-73.
    MISHRA A K, SANYASI NAIDU C. Association of cord serum albumin with neonatal hyperbilirubinemia among term appropriate-for-gestational-age neonates[J]. Int J Pediatr Adolesc Med, 2018, 5(4):142-144.
    白洁, 郑素军, 段钟平. 4种常见先天性高胆红素血症的临床特征及诊断思路[J]. 临床肝胆病杂志, 2019, 35(8):1680-1683.
    陈琳, 章浙忠, 骆丰, 等. 脐血红细胞流变学对新生儿高胆红素血症的预测分析[J]. 浙江临床医学, 2018, 20(7):1174-1176.
    杜立中. 新生儿高胆红素血症早期筛查及风险评估若干进展[J]. 现代实用医学, 2019, 31(3):281-283.
    容志惠, 罗芳, 马丽亚, 等. 基于智能手机应用软件拍照监测对新生儿高胆红素血症随访的意义[J]. 中华儿科杂志, 2016, 54(8):597-600.
    HYPERBILIRUBINEMIA S O. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J]. Pediatrics, 2004, 114(1):297-316.
    董小玥, 韩树萍, 余章斌, 等. 新生儿小时胆红素百分位曲线图的制备及早期预测高胆红素血症的初步探讨[J]. 中国循证儿科杂志, 2010, 19(3):180-186.
    HAN S, YU Z, LIU L, et al. A model for predicting significant hyperbilirubinemia in neonates from china[J]. Pediatrics, 2015, 136(4):e896-e905.
    KUTCHI I, CHELLAMMAL P, AKILA A. Maternal Obesity and Pregnancy Outcome:in Perspective of New Asian Indian Guidelines[J]. J Obstet Gynaecol India, 2020, 70(2):138-144.
    张继珍. 新生儿高胆红素血症的临床特征及预后[J]. 发育医学电子杂志, 2018, 6(3):182-185.
    ALKHAYYAT M, SALEH M A, ZMAILI M, et al. Successful liver transplantation for acute sickle cell intrahepatic cholestasis:a case report and review of the literature[J]. World J Hepatol, 2020, 12(3):108-115.
    MRZLJAK A, JUREKOVIC Z, NOVAK R, et al. Liver graft failure and bile cast nephropathy[J]. Korean J Gastroenterol, 2020, 75(3):167-173.
    何翠红, 屈艺. 新生儿高胆红素血症与基因多态性研究进展[J]. 中国当代儿科杂志, 2020, 22(3):280-284.
    李晨, 陈正, 陈鸣艳, 等. 2日龄新生儿高胆红素血症合并血小板减少[J]. 中国当代儿科杂志, 2019, 21(12):1218-1222.
    STEIN E M, FATHI A T, DINARDO C D, et al. Enasidenib in patients with mutant IDH2 myelodysplastic syndromes:a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial[J]. Lancet Haematol, 2020, 7(4):e309-e319.
    CHOI J S, CHUNG K S, LEE E H, et al. The role of bilirubin to albumin ratio as a predictor for mortality in critically ill patients without existing liver or biliary tract disease[J]. Acute Crit Care, 2020, 35(1):24-30.
    赖苑双, 黎维丹, 胡向国, 等. 高胆红素血症新生儿血红蛋白A、F与G-6-PD表达的相关性[J]. 暨南大学学报:自然科学与医学版, 2019, 40(5):411-418.
    时海波, 李春燕. 高胆红素血症所致听觉损害的临床特征及治疗现状[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(8):685-687.
    郭小青, 游绍莉, 吕飒, 等. 伴高胆红素血症不明原因肝炎的临床诊断路径及病因构成分析[J]. 解放军医学杂志, 2019, 44(4):327-331.
    杨璇, 陈富臻, 洪强. 501例新生儿溶血病筛查结果分析[J]. 中国实验血液学杂志, 2019, 27(1):192-196.
    FAAL G, KHATIB MASJEDI H, SHARIFZADEH G, et al. Efficacy of zinc sulfate on indirect hyperbilirubinemia in premature infants admitted to neonatal intensive care unit:a double-blind, randomized clinical trial[J]. BMC Pediatr, 2020, 20(1):130-138.
    ROGERS J E, MIZRAHI J, SHROFF R T, et al. Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemia[J]. J Gastrointest Oncol, 2020, 11(1):55-60.
    HAQ T U. Letter and author's reply:safety of percutaneous transhepatic biliary stenting in patients with obstructive jaundice[J]. J Coll Physicians Surg, 2020, 30(3):338-339.
  • Cited by

    Periodical cited type(13)

    1. 张新,敖利,刘正来,宋建敏,白耀武. 不同模式术后镇痛对剖宫产患者应激免疫系统的影响. 中国计划生育和妇产科. 2024(03): 36-39 .
    2. 邵满芬,高宝斌,屈百鸣,沈凯. 舒芬太尼和维生素C在妊娠期高血压疾病产妇剖宫产术后恢复中的应用效果. 中国妇幼保健. 2023(19): 3621-3625 .
    3. 周丹. 罗哌卡因复合舒芬太尼腰硬联合麻醉用于妊娠期高血压疾病剖宫产术的疗效观察. 人人健康. 2022(08): 99-101 .
    4. 李婷,刘丽丽. 全产程分娩镇痛与第一产程分娩镇痛对妊娠高血压综合征产妇产程的影响. 中国社区医师. 2022(15): 48-50 .
    5. 王逸佳,张蕾,魏旸,吴萍. 罗哌卡因复合吗啡和罗哌卡因复合舒芬太尼用于剖宫产术后硬膜外镇痛的效果对比. 中国社区医师. 2021(11): 51-52 .
    6. 王超,叶光磊,徐鑫怡,张爱荣. 轻比重罗哌卡因复合舒芬太尼在剖宫产术中最佳剂量分析. 临床和实验医学杂志. 2021(08): 890-893 .
    7. 董华,邢相记. 舒芬太尼复合罗哌卡因硬膜外麻醉在子宫切除术患者中的效果观察. 中国药物与临床. 2021(13): 2328-2330 .
    8. 裴幼程,颜青华. 盐酸罗哌卡因与盐酸布比卡因椎管内麻醉在老年股骨颈骨折手术患者中的应用比较. 江西医药. 2021(12): 2321-2323 .
    9. 万珍珍,刘华. 盐酸右美托咪定对剖宫产术后血流动力学和术后镇痛及应激反应影响. 中国性科学. 2020(07): 92-95 .
    10. 吴宇薇,符永强,宫庆娟. 舒芬太尼联合罗哌卡因对剖宫产产妇的镇痛效果研究. 实用临床医药杂志. 2020(15): 79-82 . 本站查看
    11. 赵道霞,张保应,张阿锋,蒋留琴. 舒芬太尼预防性镇痛对剖宫产术产妇VAS评分及应激指标影响. 中国计划生育学杂志. 2020(10): 1688-1690+1694 .
    12. 韩飞鹏. 连续硬膜外麻醉无痛分娩对高危产妇妊娠结局的影响. 中国社区医师. 2019(31): 74-75 .
    13. 刘英伟,王凤君. 小剂量布比卡因腰硬联合麻醉对剖宫产血流动力学及预后的影响. 黑龙江中医药. 2019(06): 181-182 .

    Other cited types(1)

Catalog

    Article views (299) PDF downloads (24) Cited by(14)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return